AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2014
May 9, 2014
30016_dirs_2014-05-09_99212825-c607-43ac-a205-b5d193ecbcde.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-05-07
Reporting Person: SZOSTAK M ANNE (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-07 | Deferred Stock Unit | $ | A | 290 | Acquired | Common Stock (290) | Direct | |
| 2014-05-07 | Non-Qualified Stock Options (right to buy) | $129.38 | A | 2987 | Acquired | 2024-05-06 | Common Stock (2987) | Direct |
Footnotes
F1: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest 100% one year from the date of grant (05/07/2014) and are payable as common stock one year following the Director's resignation from the Board of Directors.
F2: Grant of options to buy shares of common stock that vest one year from the date of grant (05/07/2014).
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26